Matches in Wikidata for { <http://www.wikidata.org/entity/Q90822159> ?p ?o ?g. }
Showing items 1 to 50 of
50
with 100 items per page.
- Q90822159 description "article scientifique publié en 2019" @default.
- Q90822159 description "artículu científicu espublizáu n'ochobre de 2019" @default.
- Q90822159 description "scientific article published on 17 October 2019" @default.
- Q90822159 description "wetenschappelijk artikel" @default.
- Q90822159 description "наукова стаття, опублікована 17 жовтня 2019" @default.
- Q90822159 name "Treatment of atopic dermatitis with ruxolitinib cream (JAK1/JAK2 inhibitor) or triamcinolone cream" @default.
- Q90822159 name "Treatment of atopic dermatitis with ruxolitinib cream (JAK1/JAK2 inhibitor) or triamcinolone cream" @default.
- Q90822159 type Item @default.
- Q90822159 label "Treatment of atopic dermatitis with ruxolitinib cream (JAK1/JAK2 inhibitor) or triamcinolone cream" @default.
- Q90822159 label "Treatment of atopic dermatitis with ruxolitinib cream (JAK1/JAK2 inhibitor) or triamcinolone cream" @default.
- Q90822159 prefLabel "Treatment of atopic dermatitis with ruxolitinib cream (JAK1/JAK2 inhibitor) or triamcinolone cream" @default.
- Q90822159 prefLabel "Treatment of atopic dermatitis with ruxolitinib cream (JAK1/JAK2 inhibitor) or triamcinolone cream" @default.
- Q90822159 P1433 Q90822159-F85040D4-9F6D-4F7F-904F-7C1D97ED02BE @default.
- Q90822159 P1476 Q90822159-9FDEBC19-8726-43CE-8679-C4E593B464ED @default.
- Q90822159 P2093 Q90822159-05251775-C836-4B74-904D-3030E89F908C @default.
- Q90822159 P2093 Q90822159-2F9CF66B-A59D-4482-A852-890C9E9D12E4 @default.
- Q90822159 P2093 Q90822159-3A0A7778-445E-4019-9B29-C314888ADECF @default.
- Q90822159 P2093 Q90822159-56B2F471-B206-435A-B7DA-2A1AB15B8050 @default.
- Q90822159 P2093 Q90822159-8CD5AAEA-C2F0-46EC-8009-3B67E651602E @default.
- Q90822159 P2093 Q90822159-9889596E-4A61-49C8-B778-5571BB5442DD @default.
- Q90822159 P2093 Q90822159-BFEE4516-41E6-4F6B-9903-991B2F13F1A4 @default.
- Q90822159 P304 Q90822159-23993CCB-887D-4258-8C35-9ED8852AF196 @default.
- Q90822159 P31 Q90822159-F61C253B-4A4D-46C0-BB97-3A226E91C8F7 @default.
- Q90822159 P356 Q90822159-6E02B9DA-9B25-4297-A3F1-A71C88963C27 @default.
- Q90822159 P433 Q90822159-B9019EB9-45FA-4407-9AB2-5FD632BB4677 @default.
- Q90822159 P478 Q90822159-C3271768-EE86-47D9-9E2C-455DFCCC2857 @default.
- Q90822159 P577 Q90822159-D6A9E833-2079-4B1C-9DBE-F33D68232A42 @default.
- Q90822159 P698 Q90822159-4F6C4258-1186-4F33-853E-B7778E719180 @default.
- Q90822159 P921 Q90822159-8F577233-D62F-455E-A75A-A71CBA9623DF @default.
- Q90822159 P921 Q90822159-EE6ABD70-5C84-4F12-81BC-69CE34EB8C16 @default.
- Q90822159 P356 J.JACI.2019.08.042 @default.
- Q90822159 P698 31629805 @default.
- Q90822159 P1433 Q7743550 @default.
- Q90822159 P1476 "Treatment of atopic dermatitis with ruxolitinib cream (JAK1/JAK2 inhibitor) or triamcinolone cream" @default.
- Q90822159 P2093 "Adnan Nasir" @default.
- Q90822159 P2093 "Brian S Kim" @default.
- Q90822159 P2093 "INCB 18424-206 Study Investigators" @default.
- Q90822159 P2093 "Kang Sun" @default.
- Q90822159 P2093 "Kim Papp" @default.
- Q90822159 P2093 "Michael D Howell" @default.
- Q90822159 P2093 "Michael E Kuligowski" @default.
- Q90822159 P304 "572-582" @default.
- Q90822159 P31 Q13442814 @default.
- Q90822159 P356 "10.1016/J.JACI.2019.08.042" @default.
- Q90822159 P433 "2" @default.
- Q90822159 P478 "145" @default.
- Q90822159 P577 "2019-10-17T00:00:00Z" @default.
- Q90822159 P698 "31629805" @default.
- Q90822159 P921 Q268667 @default.
- Q90822159 P921 Q7383611 @default.